Skip Navigation

KU Cancer Center Announces 2025 Director’s and Pilot Award Recipients at Annual Research Week

December 08, 2025

The University of Kansas Cancer Center announced its 2025 Director’s and Pilot Award recipients during Research Week, an annual event dedicated to showcasing the groundbreaking work of our researchers. These awards honor individuals and teams whose contributions drive innovation, advance cancer care and strengthen our mission. This year’s honorees include recipients of the Director’s Awards, Pilot Awards and Travel Awards each playing an important role in driving progress at the cancer center.

Director’s Award Recipients

Civic Leadership and Philanthropy 
Cinelli Family Foundation

Clinical Trial Accrual 
Tara Lin, MD, Professor, Hematologic Malignancies and Cellular Therapeutics

Community Clinical Trial Accrual 
Ryan Rader, MD, Clinical Assistant Professor, Medical Oncology

Young Scientist 
Mark Farrell, PhD, Associate Professor, Medicinal Chemistry

William Jewell Team Science 
Biostatistics and Data Science Team, including Matthew Mayo, PhD, Dinesh Pal Mudaranthakam, PhD, Devin Koestler, PhD, and Byron Gajewski, PhD

Closing Disparities 
Joseph Hines II, MPH, Senior Director, Research Operations, Director, CAREERS in CLINICAL RESEARCH (C-CLEAR) program

Basic Science 
Wen-Xing Ding, PhD, Professor, Pharmacology, Toxicology & Therapeutics

Clinical Science 
Tara Lin, MD, Professor, Hematologic Malignancies and Cellular Therapeutics

Outstanding Staff 
Christine Thomas, JD, Senior Director, Public Relations, Communications and Strategic Partnerships

Mentoring
Shrikant Anant, PhD, Professor, Cancer Biology

Pilot Project Recipients 

Awardees receiving $50,000 in funding.

Bret Freudenthal - DHX36 as a Novel Regulator of Base Excision Repair and Innate Immunity

Mohammad Haeri - Spatially Resolved Identification of Phase-Specific Markers of Mitosis in Brain Tumors Using Integrated Spatial Proteomics and Transcriptomics

Fariba Behbod - Discovery of epigenomic drivers of ductal carcinoma in situ (DCIS) malignant progression to enable precision prevention and therapeutic targeting

Gregory Gan - Development of a recurrent-metastatic head and neck cancer microphysiological system as a step towards precision medicine

Carlo Barnaba – Mechanisms of Autophagy Modulation by Metformin in Hepatocellular Carcinoma

Travel Award Recipients 

Recipients receive support to attend conferences and/or scientific meetings.

Trainee Speaker Awardees

Cancer Prevention and Control research program: Reagan Henry - Human Ductal Carcinoma in Situ: Mechanism of Early Dissemination and Metastasis.

Drug Discovery, Delivery and Experimental Therapeutics research program: Omar Tinoco - Engineering nanoparticle-drug loaded CAR T-cells to overcome immune suppression in solid tumors

Cancer Biology research program: Allison St. John - Depletion of dominant-negative mutant p53 improves the efficacy of mutant p53 reactivators

PIVOT Speaker Awardees

Cancer Prevention and Control research program: Md Atikur Rahman - Historical Redlining as a Structural Determinant of Breast Cancer Screening: Evidence from a Regional Spatial Analysis

Drug Discovery, Delivery and Experimental Therapeutics research program: Omar Tinoco - Engineering nanoparticle-drug loaded CAR T-cells to overcome immune suppression in solid tumors

Cancer Biology research program: Alec M. Bevis - The autoimmunity-associated minor allele of PTPN22 accelerates NK cell development and augments effector function

Poster Travel Awardees

Student Recipients

1st Place (3-way tie for $1,000 each)
Kaustubh S. Nimkar: Prediction and monitoring of accrual and rate of underrepresented biomedical research group using Bayesian methods
Md Atikur Rahman: Historical Redlining as a Structural Determinant of Breast Cancer Screening: Evidence from a Regional Spatial Analysis
Aditi Rastogi: Elucidating the role of NEAT1_2 in DCIS malignancy 

2nd Place ($500)
Jared Sipes: Tracing the early origins of ovarian cancer: The emerging role of extracellular vesicles

3rd Place ($300)
Aprajita Tripathi: NRF2 as a therapeutic target to improve T cell function in muscle invasive bladder cancer (MIBC)

Trainee Recipients

1st Place ($1,000)
Garrett R. Gibson: Cannabidiol (CBD), Overcomes ONC201 Resistance in H3K27M-Mutant Diffuse Midline Gliomas (DMGs) by Targeting Master Transcription Regulator ID1

2nd Place ($500)
Anika James: Nuclear APC Maintains Colon Homeostasis and Mitigates Inflammation

3rd Place ($300)
Piyanka Hettiarachchi: The critical role of CRK and CRKL in glioblastoma migration and invasion at the cellular level and in the mouse brain

Junior Faculty Recipients

1st Place ($1,000)
Kalyani Pyaram: Tuning T cell immunity through NRF2 modulation: Suppressing Th1/Th17-driven IBD and amplifying CD8⁺ cytotoxicity in solid tumors

2nd Place ($500)
Jacqelyn Nemechek: Unveiling the Function of Chromatin Reader ZMYND8 in Enhancing Anti-Cancer Immunotherapy through PD-L1

3rd Place ($300)
Hindole Ghosh: Ebastine induced inhibition of histaminergic-neurotrophin loop to inhibit pancreatic cancer progression under chronic stress conditions

Explore more news, events and blog